Key facts
- This page summarizes John Strahley's Form 4 filing for Aspira Women's Health Inc. (AWHL).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 02 Oct 2026, 17:00.
John Strahley - 08 Sep 2026 Form 4 Insider Report for Aspira Women's Health Inc. (AWHL)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- AWHL
- Reported as of
- 08 Sep 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Oct 2026, 17:00:35 UTC
- Prior SEC filing
- 17 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Strahley
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John Strahley filed Form 4 for Aspira Women's Health Inc. (AWHL) on 02 Oct 2026.
Change
- Previous filing in this sequence was filed on 17 Jul 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001875425
Primary reporting owner
Strahley John
- Relationship
- Chief Financial Officer
- Address
- C/O ASPIRA WOMEN'S HEALTH INC., 12117 BEE CAVES RD, BLDG 3-100, AUSTIN
- Signature
- /s/ John Strahley
- Signature date
- 02 Oct 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AWHL
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +97,417
- Change %
- Price
- $0.000000*
- Shares after
- 97,417
- Date
- 08 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 97,417
- Exercise price
- $0.3000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
48,708 shares vested on September 15, 2026. 24,354 shares vested on September 30, 2026. 24,355 shares will vest on October 15, 2026.